AI
Amazon Locks Anthropic Into Over $100B AWS Deal, Adds $5B
Amazon just wrote Anthropic a $5 billion check and got an over $100 billion cloud commitment in return: ten years, up to 5 gigawatts of Trainium capacity…
Latest — Page 13
AI
Google Rewires Enterprise AI Stack With A2A Protocol at 150 Organizations
At Cloud Next 2026, Thomas Kurian delivered a platform thesis, not a product announcement.
AI
Google Commits $40B to Anthropic at $380B Valuation
Google just committed up to $40 billion to Anthropic, with $10 billion hitting immediately at a $380 billion valuation and the remaining $30 billion tied to…
AI
Vercel Loses Customer API Keys in Context AI Supply Chain Attack
Your team's OAuth integrations just became a supply chain liability.
Deals
Kailera Raises Record $625M IPO on Hengrui GLP-1 Pipeline
Kailera Therapeutics raised $625 million in a record IPO for an obesity biotech.
Deals
Regeneron Closes MFN Deal, Completing 17-Company White House Sweep
Regeneron signed the White House's most-favored-nation drug pricing deal Thursday, becoming the 17th and final company to do so — closing out a sweep that…
AI
Prosecute China for AI Model Theft, Congress Tells State Department
Congress wants Chinese AI firms prosecuted under federal law for what it's calling industrial espionage, and your export-control playbook needs updating…
FDA
FDA Cleared Regeneron's Otarmeni; Last Big Pharma Signs MFN Deal
FDA cleared Otarmeni, Regeneron's hearing loss gene therapy, on Thursday, the same day the pharma ended nearly nine months of resistance and agreed to Most…
Legal
Filed: H.R. 8413 Could Preempt Illinois BIPA, California's Delete Act
The House Energy and Commerce Committee's Republican data privacy working group filed H.R. 8413, the SECURE Data Act, on April 22.
FDA
FDA Cleared Regeneron's $0 Gene Therapy for Rare Hearing Loss
FDA cleared Regeneron's Otarmeni today, the first approved gene therapy for otoferlin-driven hearing loss.
FDA
FDA Clears Regeneron Otarmeni, First Hearing Gene Therapy
FDA cleared Otarmeni, giving Regeneron the first-ever approval for a gene therapy to treat a rare type of inherited hearing loss.
Deals
AbbVie Builds $1.4B Durham Campus, First in North Carolina
AbbVie has allocated $1.4 billion for a manufacturing campus in Durham, North Carolina, its first in the state, drawn from the company's $100 billion US…
FDA
FDA Warns New Life Pharma After GLP-1 Inspection Refusal
FDA issued a warning letter to New Life Pharma on April 14 after the company's New Jersey facility blocked inspectors from two sections of its GLP-1…
Legal
Fined $30.5M in 2017, SQM Now Faces Resumed SEC FCPA Probe
The SEC issued SQM a subpoena in November 2023 under the Foreign Corrupt Practices Act, covering the Chilean miner's operations, compliance program, and…
Deals
Cut $1B Google Cloud Deal, Merck Targets HCP Engagement
Merck paid $1 billion to Google Cloud for access to its agentic AI platform, and the commercial team gets there first.
